American States Water is a holding company. The company is the parent company of Golden State Water Company (GSWC) and American States Utility Services, Inc. (ASUS). The company segments are: water, electric and contracted services. Within the segments, the company has two principal business units: water and electric service utility operations conducted through GSWC, and contracted services conducted through ASUS and its subsidiaries. GSWC is engaged in the purchase, production, distribution and sale of water as well as distributes electricity in California. ASUS, through its subsidiaries has contracted with United States government to provide water and/or wastewater services at various military installations.

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of unmet medical need. The company's main product candidate, AT-007, is a central nervous system, penetrant AR inhibitor (ARI) that the company is developing for the treatment of galactosemia, a rare pediatric metabolic disease that affects how the body processes a simple sugar called galactose. The company's second product candidate, AT-001, is an ARI with systemic exposure and peripheral nerve permeability that the company is developing for the treatment of diabetic cardiomyopathy, a fatal fibrosis of the heart.

Cardiovascular Systems is a medical technology company. The company has developed an orbital atherectomy systems (OAS) for both peripheral and coronary commercial applications. The primary base of the company's business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. The company's products include its coronary arterial disease (CAD) product, the Diamondback 360 Coronary OAS, which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.

EchoStar is a holding company. Through its subsidiaries, the company is a global provider of broadband satellite technologies, broadband internet services for home and small office customers, satellite operations and satellite services. The company operates in two business segments: Hughes, which provides broadband satellite technologies and broadband internet services and broadband network technologies, managed services, equipment, hardware, satellite services and communications solutions; and EchoStar Satellite Services, which uses certain of the company's owned and leased in-orbit satellites and related licenses to provide satellite service operations and satellite services.

Equitrans Midstream, through its subsidiary EQM Midstream Partners, LP (EQM), is one of the natural gas gatherer in the United States. The company through its control of EQM, provides midstream services to its customers in Pennsylvania, West Virginia and Ohio via its three key assets: the gathering system, which delivers natural gas from wells and other receipt points to transmission pipelines; the transmission and storage system, which delivers natural gas to local demand users and long-haul interstate pipelines for access to demand markets; and the water service system, which consists of water pipelines, impoundment facilities, pumping stations, take point facilities and measurement facilities.

Goosehead Insurance is a holding company. Through its subsidiaries, the company is an independent personal lines insurance agency. The company provides consumers with insurance coverage. The company's insurance product offerings primarily consist of homeowner's insurance; auto insurance; other personal lines products, including flood, wind and earthquake insurance; excess liability or umbrella insurance; other lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property and auto insurance for small businesses); and life insurance.

lululemon athletica is a designer, distributor, and retailer of athletic apparel. Co.'s athletic apparel is marketed under the lululemon and ivivva brand names. Co. provides a line of apparel and accessories for women, men and female youth. Co.'s apparel assortment includes items such as pants, shorts, tops, and jackets designed for healthy lifestyle and athletic activities such as yoga, running, training, other sweaty pursuits, and athletic wear for female youth. Co. also provides fitness-related accessories. Co. primarily conducts its business through two channels: company-operated stores and direct to consumer. As of Jan 28 2018, Co. operated 404 stores.

Neurocrine Biosciences is a commercial-stage biopharmaceutical company focused on discovering and developing treatments for patients with neurological, endocrine and psychiatric disorders. The company is primarily focused on the commercialization of INGREZZA? (valbenazine) in the United States. The company's late-stage pipeline includes opicapone as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors in adult Parkinson's disease patients, elagolix for the treatment of heavy menstrual bleeding associated with uterine fibroids in women, valbenazine for the treatment of chorea in adult patients with Huntington's disease and NBIb-1817 (VY-AADC) for the treatment of Parkinson's disease patients.

SailPoint Technologies Holdings is a provider of enterprise identity governance solutions. The company's SailPoint Predictive Identity platform provides organizations with visibility into who has access to which resources, who should have access to those resources, and how that access is being used. The company delivers an integrated set of solutions to address identity governance challenges for enterprises. The company's products include: IdentityIQ, which is an on-premises identity governance solution; IdentityNow, which is a cloud-based, multi-tenant identity governance platform; and IdentityAI, which is a multi-tenant artificial intelligence and machine learning software as a service subscription offering.

Uranium Participation is an investment fund. Co. invests in, holds and sells uranium oxide in concentrates and uranium hexafluoride (collectively "uranium"). The investment objective of Co. is to achieve long-term appreciation in the value of its uranium holdings through a buy and hold investment strategy and not actively speculate with regard to short-term changes in uranium prices.

Venus Concept is a medical technology company developing and commercializing a robotic device, the ARTAS? System, that assists physicians in performing tasks that are a part of a follicular unit extraction surgery. The ARTAS? System includes the ARTAS Hair Studio application, a three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The ARTAS? System is comprised of the patient chair, the cart, which includes the robotic arm, vision system, artificial intelligence algorithms and a series of proprietary end effectors, which are the various devices at the end of the robotic arm.